Two Different Responsive Organosilica Nanocarriers to Combine Chemo- and Immunotherapy against Cancer

• Maria Sancho-Albero,
• Alessia Lucrezia Fenaroli,
• Mirco Scaccaglia,
• Cristina Matteo,
• Chiara Grasselli,
• Massimo Zucchetti,
• Roberta Frapolli,
• Claudia Nastasi,
• Luisa De Cola

Affiliations

Maria Sancho-Albero

Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Alessia Lucrezia Fenaroli

Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Mirco Scaccaglia

Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Cristina Matteo

Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Chiara Grasselli

Department of Oncology, Immunopharmacology Unit, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Massimo Zucchetti

Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Roberta Frapolli

Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Claudia Nastasi

Department of Oncology, Immunopharmacology Unit, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy

Luisa De Cola

Department of Pharmaceutical Science, DISFARM, Università degli Studi di Milano, Milan, Italy